About Us
Hope Shield
LifeGuard
.png)
Treatment
.png)
Our Vision
Our vision is to redefine cancer treatment standards with innovative therapies that precisely and powerfully target cancer cells, offering hope and better outcomes for all patients.
Development
Background
Developed by Saint Louis University scientists, our groundbreaking therapy uses the NK 3.3 cell line, a unique human NK cell line capable of eradicating various tumor types. These cells release NKEVs—potent, membrane-bound particles with natural cancer-fighting properties. NKEVs are easy to store, ship, and administer, making them accessible to cancer centers worldwide without specialized equipment or training.
.png)
Transformation
Our Mission
At Vanquish Bio, we aim to transform cancer care, turning it from a life-threatening disease into a manageable challenge. By leveraging the innate power of natural killer (NK) cell-derived extracellular vesicles (NKEVs), we are creating safe, effective, and accessible therapies to combat the most aggressive cancers.
.png)